IDEXX Laboratories (IDXX) Revenue — Quarter Ended Sep 30, 2024
Revenue declined in the current quarter compared to the immediate prior quarter. The figure rose compared to the same quarter one year earlier.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue declined in the current quarter compared to the immediate prior quarter. The figure rose compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$975.5M
Revenue reported for this quarter.
Quarter-over-quarter
-2.8%
Change from the immediately preceding quarter.
Year-over-year
+6.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $901.6M | +8.8% |
| Mar 31, 2024 | $964.1M | +7.1% |
| Jun 30, 2024 | $1B | +6.4% |
| Sep 30, 2024 | $975.5M | +6.6% |
Revenue performance
The reported revenue moved downward from the preceding quarter, reflecting a sequential contraction. The trailing twelve-month revenue remained elevated relative to earlier periods.
Quarterly comparison
Compared with the immediately preceding quarter, the outcome was lower. Compared with the same quarter last year, the result was higher.
What to watch
The sequential decline in revenue may warrant attention given the prior trend of consecutive year-over-year increases.